For example, vascular endothelial growth factor inhibitors (VEGFIs) improve tumor microenvironment and enhance the efficacy of immunotherapy by normalizing blood vessels and promoting the infiltration and activation of immune cells, including effector T cells (Ren et al., 2021). The gene discussed is VEGFA; the disease is neoplasm.